 |
|
|
| Pharmacoepidemiology is a natural crossing of two specialties: clinical pharmacology and clinical epidemiology. It aims to describe, explain, predict, and control the uses and effects (beneficial and adverse events) of drugs and biologics in human populations through the chemistry, manufacturing, and control (CMC) evaluations, non-clinical analyses, and clinical trial design. We also perform active research and development of novel immunotoxins, cytotoxins and cancer vaccines for the treatment of cancer. |
Department of Pharmacoepidemiology
Graduate School of Medicine and Public Health, Kyoto University |
|
| Professor and Chairman: Koji Kawakami, MD, PhD |
|
 |
Yoshida Konoecyo, Sakyoku, Kyoto 606-8501, Japan |
|
 |
+81-75-753-9469 |
|
 |
+81-75-753-4469 |
|
 |
pe |
 |
z59147.mhost1.iimc.kyoto-u.ac.jp |
|
|
|
|
